AJOVista’s Mirum Pharmaceuticals MIRM Stock Holding History

AJOVista’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,364	Closed	-$40.3K	–	271
2023 Q4	$40.3K	Buy	+1,364	New	+$41.3K	0.05%	314

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AJOVista's MIRM Position: Q1 2024 in Review

AJOVista sold out of Mirum Pharmaceuticals (MIRM) in Q1 2024, closing a stake of 1,364 shares — an estimated $40.3K sold.

AJOVista first reported a position in MIRM in Q4 2023 and held it in 1 quarter. The position peaked at $40.3K in Q4 2023. 172 funds tracked by Wall St. Rank hold MIRM as of Q1 2024.

AJOVista reported no remaining Mirum Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
AJOVista sold 1,364 Mirum Pharmaceuticals shares in Q1 2024, an estimated $40.3K.
AJOVista first reported a position in Mirum Pharmaceuticals in Q4 2023 and held it in 1 quarter.
AJOVista's Mirum Pharmaceuticals position peaked at $40.3K in Q4 2023.
172 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.